|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-6-8
|
|
pubmed:abstractText |
To compare the efficacy of a controlled-release (CR) formulation of oxybutynin with that of conventional oxybutynin in patients with detrusor instability or detrusor hyper-reflexia whose symptoms were stabilized on conventional oral oxybutynin tablets.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-4096
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
793-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10792154-Adolescent,
pubmed-meshheading:10792154-Adult,
pubmed-meshheading:10792154-Aged,
pubmed-meshheading:10792154-Cholinergic Antagonists,
pubmed-meshheading:10792154-Delayed-Action Preparations,
pubmed-meshheading:10792154-Female,
pubmed-meshheading:10792154-Humans,
pubmed-meshheading:10792154-Male,
pubmed-meshheading:10792154-Mandelic Acids,
pubmed-meshheading:10792154-Middle Aged,
pubmed-meshheading:10792154-Parasympatholytics,
pubmed-meshheading:10792154-Tablets
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin.
|
|
pubmed:affiliation |
Department of Medicine, University College London Hospital, Leiras Oy Clinical Research, Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
